Effect of Cardio Mato (Grade A Lyc-O-Mato, a Tomato Extracted Lycopene) on Blood Pressure

Prehypertension Clinical Trial

Official title:

Effect of Cardio Mato (Grade A Lyc-O-Mato, a Tomato Extracted Lycopene) on Blood Pressure and Serum Lycopene, Phytofluene, and Phytoene Levels in Pre-hypertensive Otherwise Healthy Subjects

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01667510
• Other study ID #: Lyc-2012-01
• Status: Completed
• Phase: N/A
• First received: August 12, 2012
• Last updated: December 21, 2017
• Start date: August 2012
• Est. completion date: August 2013

Study information

• Verified date: August 2012
• Source: LycoRed Ltd.
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The hypothesis of the study is that supplementation with Cardio Mato (a Tomato Extracted Lycopene)for 12 weeks will decrease the blood pressure of subjects with prehypertension compared to Placebo.

Description:

Blood-pressure reading of 140/90 mmHg (systolic/diastolic pressure) are typically regarded as having high blood pressure as defined in the most recent guidelines. From a physiological perspective, the regulation of blood pressure is a complicated process involving different biological systems and a number of feedback systems, including the nervous system, hormones, control of body fluid and regulators within the vessels themselves. In 90-95% of patients with high blood pressure the cause is unknown, whereas the remaining 5-10% may have secondary hypertension related to congenital heart defects, certain cancers or kidney abnormalities. Prehypertension [systolic blood pressure (SBP) 120-139 mm Hg, diastolic blood pressure (DBP) 80-89 mm Hg] is considered a precursor of hypertension and has been associated with an increased risk of up to 3.5 times in cardiovascular morbidity and mortality later in life.

According the report of the Joint National Committee on High Blood Pressure (JNC 7) and other international guidelines, weight control, reduced intake of salt and reduced alcohol consumption, as well as increase of potassium are recommend nutritional approaches to prevent and treat hypertension. In observational studies significant inverse association between high blood pressure and vegetarian diet rich in fibers, magnesium, potassium, calcium and protein have been reported. In addition various studies demonstrated the ability of antioxidant vitamins of natural origin to improve vascular function.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 80
• Est. completion date: August 2013
• Est. primary completion date: June 2013
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

1. Male and female subjects aged 18-65, both inclusive

2. Established Pre-hypertension defined as: Mean baseline SBP 130-139 mmHg and DBP of 89 mmHg or lower or SBP of 139 mmHg or lower and DBP of 85- 89 mmHg, at screening, eligibility and randomization visits

3. Subjects that did not receive any antihypertensive treatment in the past o present

4. Subjects that are willing to sign an informed consent form prior to joining the study

Exclusion Criteria:

1. Subjects with Mean baseline SBP higher than 120 and lower than 130 mmHg

2. Subjects with Mean baseline DBP higher than 80 and lower than 85 mmHg

3. Subjects who are treated for blood pressure reduction (any treatment)

4. Subjects under treatment with other chronic medications (e.g. statins, NSAID etc.)

5. Subjects that use antioxidant agents or vitamins within 4 weeks prior to inclusion into the study

6. Subjects that will not be able to follow the study dietary proscriptions from the screening visit through the final visit

7. Subjects following any special diet including, but not limited to liquid, high or low protein, raw food, vegetarian or vegan, etc

8. Subjects with known allergy to tomatoes, carotenoids, or vitamin E

9. Subjects diagnosed with Diabetes Mellitus

10. Subjects suffering from obesity

11. Subjects Suffering from a clinically significant dyslipidaemia

12. Subjects suffering from cardiac disease; e.g. suffering from cardiac angina, subjects that were diagnosed with and MI, subjects that needed PTCA or CABG. Subjects diagnosed with LVH, CHF or valvular heart disease

13. Subjects diagnosed with PVD

14. Subjects who were diagnosed with Cerebrovascular disease, s/p CVA, TIA

15. Subjects who suffer from any kind of kidney disease

16. Subjects who suffer from chronic liver disease; defined as elevated AST and ALT at least by 2 times of the normal range

17. Subject with history or current use of illegal or "recreational" drugs

18. Subjects with a history of GI disease or surgery within 6 months prior to study inclusion

19. Subjects with a history of malignancy in the past 5 years

20. Subjects with a history of autoimmune disease

Related Conditions & MeSH terms

• Prehypertension

Intervention

Dietary Supplement:
• Cardio Mato
Soft gel capsule for oral use
• Placebo
Soft gel capsule without test material

Locations

Country	Name	City	State
Israel	Maccabi Health care, outpatient clinic	Holon

Sponsors (2)

Lead Sponsor	Collaborator
LycoRed Ltd.	Maccabi Healthcare Services, Israel

Country where clinical trial is conducted

Israel, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Number of adverse events recorded during the supplementation period, lycopene compared to placebo	AE epizoda	12 weeks
Primary	The effect Lyc-O-Mato on the blood pressure of pre-hypertensive otherwise healthy subjects compared to the placebo group following 12 weeks of treatment	Change in blood pressure from baseline to 12 weeks in mmHG	12 weeks
Secondary	The effect Cardio Mato on the blood pressure of Pre-hypertensive otherwise healthy subjects compared to the placebo group following 4 and 8 weeks of treatment	Change in blood pressure from baseline to 4 and 8 weeks in mmHG	4-8 weeks
Secondary	The correlation between B.P changes in the Cardio Mato or placebo treatment arms during the study with serum lycopene phytofluene, and phytoene levels	B.P change	12 weeks

External Links

•   Data on tomato extracted lycopene